Ulf Dittmer Selected Research

Neutralizing Antibodies

1/2023	Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5.
1/2022	Establishment and clinical validation of an in-cell-ELISA-based assay for the rapid quantification of Rabies lyssavirus neutralizing antibodies.
1/2021	Declining Levels of Neutralizing Antibodies Against SARS-CoV-2 in Convalescent COVID-19 Patients One Year Post Symptom Onset.
1/2021	SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19.
8/2020	Herpes Simplex Virus Type 2 Is More Difficult to Neutralize by Antibodies Than Herpes Simplex Virus Type 1.
1/2019	Immunization with a murine cytomegalovirus based vector encoding retrovirus envelope confers strong protection from Friend retrovirus challenge infection.
2/2015	CEACAM1 induces B-cell survival and is essential for protective antiviral antibody production.
5/2013	The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies.
1/2011	Complement opsonization enhances friend virus infection of B cells and thereby amplifies the virus-specific CD8+ T cell response.
8/2004	Essential role for virus-neutralizing antibodies in sterilizing immunity against Friend retrovirus infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ulf Dittmer Research Topics

Disease

114	Infections 03/2024 - 06/2001
44	Virus Diseases (Viral Diseases) 02/2024 - 06/2001
35	COVID-19 03/2024 - 01/2020
17	Retroviridae Infections (Infection, Retrovirus) 01/2023 - 03/2002
16	Neoplasms (Cancer) 10/2023 - 10/2003
12	Persistent Infection 01/2022 - 06/2001
12	Chronic Hepatitis B 01/2022 - 01/2013
11	HIV Infections (HIV Infection) 10/2022 - 10/2011
6	Coinfection 01/2022 - 11/2012
5	Viremia 01/2022 - 01/2003
5	Leukemia 11/2010 - 11/2002
4	Inflammation (Inflammations) 10/2022 - 11/2017
3	Hepatitis B 01/2022 - 01/2021
3	Disease Progression 11/2020 - 10/2003
3	Communicable Diseases (Infectious Diseases) 01/2013 - 10/2003
2	Critical Illness (Critically Ill) 01/2023 - 01/2021
2	Breakthrough Infections 01/2023 - 01/2022
2	Thromboinflammation 01/2023 - 01/2021
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 08/2013
2	Chronic Renal Insufficiency 09/2021 - 01/2021
2	Epstein-Barr Virus Infections 11/2020 - 01/2019
2	Melanoma (Melanoma, Malignant) 01/2020 - 01/2020
2	Herpetic Keratitis 01/2019 - 12/2017
2	Blindness (Hysterical Blindness) 01/2019 - 01/2015
2	Acute Retinal Necrosis Syndrome 12/2017 - 01/2017
2	Splenomegaly 05/2016 - 01/2013

Drug/Important Bio-Agent (IBA)

49	Antiviral Agents (Antivirals)IBA 02/2024 - 11/2002
25	VaccinesIBA 01/2023 - 06/2001
21	AntibodiesIBA 01/2023 - 08/2004
19	InterferonsIBA 10/2023 - 10/2011
17	CytokinesIBA 05/2020 - 06/2001
16	Interferon Type IIBA 02/2024 - 04/2006
14	AntigensIBA 01/2023 - 07/2004
12	Proteins (Proteins, Gene)FDA Link 07/2023 - 08/2007
12	Immunoglobulin G (IgG)IBA 01/2023 - 12/2016
10	Neutralizing AntibodiesIBA 01/2023 - 08/2004
10	LigandsIBA 01/2018 - 03/2010
9	RNA (Ribonucleic Acid)IBA 01/2022 - 09/2013
8	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022 - 01/2016
8	Messenger RNA (mRNA)IBA 01/2022 - 01/2003
7	Granzymes (Granzyme)IBA 01/2020 - 12/2004
6	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018 - 12/2007
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2013
5	Interferon-alpha (Interferon Alfa)IBA 01/2022 - 01/2012
5	Complement System Proteins (Complement)IBA 01/2019 - 04/2010
5	OligodeoxyribonucleotidesIBA 04/2007 - 11/2002
4	Immune Checkpoint InhibitorsIBA 08/2023 - 11/2017
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 03/2010
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2021
4	InterleukinsIBA 01/2023 - 10/2011
4	Hepatitis B e AntigensIBA 01/2022 - 01/2020
4	PerforinIBA 01/2020 - 01/2003
4	Monoclonal AntibodiesIBA 01/2019 - 02/2011
4	Glycoproteins (Glycoprotein)IBA 01/2019 - 01/2015
4	Interleukin-6 (Interleukin 6)IBA 05/2015 - 06/2001
4	CPG-oligonucleotideIBA 05/2004 - 11/2002
3	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2020
3	Alanine Transaminase (SGPT)IBA 01/2022 - 11/2021
3	Nucleic AcidsIBA 01/2022 - 01/2021
3	PolymersIBA 01/2022 - 01/2021
3	Immunoglobulin M (IgM)IBA 01/2021 - 11/2017
3	Interleukin-2 (IL2)IBA 01/2020 - 02/2013
3	Viral AntigensIBA 01/2019 - 09/2011
3	Acyclovir (Aciclovir)FDA LinkGeneric 01/2019 - 01/2015
3	Interleukin-15 (Interleukin 15)IBA 11/2017 - 11/2016
3	Interleukin-12 (IL 12)IBA 01/2017 - 01/2003
2	N-(2-cyanoethylene)urea (BA 1)IBA 03/2024 - 01/2023
2	AutoantibodiesIBA 01/2023 - 01/2022
2	von Willebrand FactorIBA 01/2023 - 01/2021
2	EnzymesIBA 01/2023 - 08/2017
2	Oxygen (Dioxygen)IBA 01/2023 - 12/2017
2	remdesivirIBA 11/2022 - 01/2021
2	Protein Isoforms (Isoforms)IBA 01/2022 - 01/2020
2	N-(4-aminophenethyl)spiroperidol (NAPS)IBA 11/2021 - 01/2020
2	Antigen-Antibody Complex (Immune Complex)IBA 11/2021 - 01/2021
2	Tenofovir (Viread)FDA Link 11/2021 - 01/2020
2	Amino Acids FDA Link 10/2021 - 11/2012
2	Interferon-betaIBA 01/2021 - 03/2010
2	Interleukin-7 (Interleukin 7)IBA 01/2020 - 10/2011
2	Viral DNAIBA 12/2019 - 01/2018
2	CEACAM1 ProteinIBA 01/2018 - 02/2015
2	Interleukin-10 (Interleukin 10)IBA 01/2018 - 06/2001
2	Interferon-gamma (Interferon, gamma)IBA 12/2017 - 03/2002
2	Interleukin-18 (Interleukin 18)IBA 11/2017 - 11/2016
2	Fas Ligand Protein (Fas Ligand)IBA 10/2017 - 12/2004
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2017 - 04/2008
2	Peptides (Polypeptides)IBA 01/2016 - 07/2007
2	Surface Antigens (Surface Antigen)IBA 01/2016 - 07/2007
2	Interleukin-5 (Interleukin 5)IBA 01/2013 - 06/2001
2	EpitopesIBA 11/2012 - 08/2007
2	DNA VaccinesIBA 12/2008 - 08/2007
1	Sertraline (Zoloft)FDA LinkGeneric 03/2024
1	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 03/2024
1	Fluoxetine (Prozac)FDA LinkGeneric 03/2024

Therapy/Procedure

32	Therapeutics 02/2023 - 10/2003
20	Immunotherapy 10/2023 - 03/2004
2	Drug Therapy (Chemotherapy) 01/2022 - 04/2013
2	Critical Care (Surgical Intensive Care) 01/2021 - 12/2020
2	Kidney Transplantation 11/2020 - 11/2020
2	Transplantation 02/2018 - 12/2013